C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias

Scene: Alzheimer’s Therapeutic Research Institute

The Alzheimer’s Therapeutic Research Institute of the University of Southern California recently hosted its 10th anniversary gala at the Evans Garage Museum in San Diego. The evening brought together researchers, supporters and community leaders to mark the progress made against the disease and to look to the future of care. USC leaders traveled from Los Angeles to acknowledge their colleagues based in San Diego. These included USC’s interim Pre…

Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau

The repeated failures of amyloid-targeting therapies have challenged our narrow understanding of Alzheimer’s disease (AD) pathogenesis and inspired wide-ranging investigations into the underlying mechanisms of disease. Increasing evidence indicates that AD develops from an intricate web of biochemical and cellular processes that extend far beyond amyloid and tau accumulation. This growing recognition surrounding the diversity of AD pathophysiolo…

C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias

ST. LOUIS--(BUSINESS WIRE)--Jul 15, 2025-

Researchers Trial THC/CBD For Dementia-Related Agitation at End of Life

A trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia.